Concepedia

Author

P Sensi

LETI Pharma (Germany)

Also Known As

P SENSI, P Sensi, P. SENSI, P. Sensi, Piero Sensi, Piero. Sensi

63

Publications

1.5K

Citations

18

H-Index

38

Concepts

All Affiliations

LETI Pharma (Germany)
PS

About

P Sensi is an author at LETI Pharma (Germany) specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

19

1.1K

2

Natural Sciences

7

7

433

3

Biochemistry

6

6

428

4

Health Sciences

4

4

366

5

Engineering

1

1

20

P Sensi

×

23

Publications

1.2K

Citations

17

H-Index

YearCitations

History of the Development of Rifampin

P Sensi

Clinical Infectious Diseases

1983

302

Rifampicin: A New Orally Active Rifamycin

N. Maggi, C.R. Pasqualucci, R Ballotta,

Chemotherapy

1966

266

Alanosine, a New Antiviral and Antitumour Agent isolated from a Streptomyces

Y. K. S. Murthy, J. E. Thiemann, C. Coronelli,

Nature

1966

80

Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex.

P Sensi, Greco Am, R Ballotta

PubMed

1998

69

Chemical modifications and biological properties of rifamycins.

P Sensi, N Maggi, S Fürész,

PubMed

1966

63

ISOLATION AND STRUCTURE OF RIFAMYCIN L AND ITS BIOGENETIC RELATIONSHIP WITH OTHER RIFAMYCINS

G. G. LANCINI, G.G. Gallo, Giuseppe Sartori,

The Journal of Antibiotics

1969

41

THERMORUBIN, A NEW ANTIBIOTIC FROM A THERMOACTINOMYCETE.

R. Craveri, C. Coronelli, H. Pagani,

PubMed

1964

34

New derivatives of rifamycin SV.

N. Maggi, R Pallanza, P Sensi

PubMed

1965

34

The conformation of rifamycin S in solution by 1H NMR spectroscopy

G.G. Gallo, E. Martinelli, V. Pagani,

Tetrahedron

1974

33

Rifamycins.<sup>1</sup> XXXV.<sup>2</sup> Amides and Hydrazides of Rifamycin B<sup>3</sup>

P Sensi, N. Maggi, R Ballotta,

Journal of Medicinal Chemistry

1964

31

Page 1